Israel vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Cause of death, by non-communicable diseases, female

Israel
80.9%
in 2021
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
61.9%
in 2021
Israel rank
33rd
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
30th

Cause of death, by non-communicable diseases, female over time

  • Israel
  • Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
020406080200020102021

How they compare

Israel currently reports 80.9% against 61.9% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 19.0%.

That makes Israel's figure about 1.3 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.

Across all 6 years both countries report, Israel has been ahead every year.

Israel ranks 33rd and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 30th of 185 countries.

Israel has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Israel Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) Difference Ahead
2000s 89.2% 52.9% 36.3% Israel
2010s 86.9% 66.5% 20.4% Israel
2020s 81.4% 63.0% 18.4% Israel

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cause of death, by non-communicable diseases, female, Israel or Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
Israel, at 80.9% against 61.9% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2021.
What is the difference in cause of death, by non-communicable diseases, female between Israel and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
19.0%, with Israel ahead.
How many years of comparable data are there for Israel and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
6 years are reported by both, from 2000 to 2021.
How do Israel and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank globally for cause of death, by non-communicable diseases, female?
Israel ranks 33rd and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 30th of 185 countries.
Where does this data come from?
Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Israel vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Cause of death, by non-communicable diseases, female. Statizoid, drawing on Global Health Estimates, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-female-percent-of-total-female-deaths/israel/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-female-percent-of-total-female-deaths/israel/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/">Israel vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Cause of death, by non-communicable diseases, female</a> — Statizoid

About this data

Indicator
Cause of death, by non-communicable diseases, female (% of total female deaths)
Unit
% of total female deaths
Source
Global Health Estimates, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 1,392 data points, 2000–2021
Last refreshed

Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.